Product Images Sumatriptan Succinate
View Photos of Packaging, Labels & Appearance
Product Label Images
The following 4 images provide visual information about the product associated with Sumatriptan Succinate NDC 33261-662 by Aidarex Pharmaceuticals Llc, such as packaging, labeling, and the appearance of the drug itself. This resource could be helpful for medical professionals, pharmacists, and patients seeking to verify medication information and ensure they have the correct product.
chemical-structure - sumatriptan succinate 25mg 1
Sumatriptan-figure-1 - sumatriptan succinate 25mg 2
This figure displays the estimated probability of achieving initial headache relief within 4 hours of treatment using oral sumatriptan. The chart shows the probability of response over time and includes different doses of medication, including placebo. The data is based on pooled information from 3 clinical trials and is presented using a Kaplan-Meier plot with censoring at 240 minutes for patients who did not respond or needed additional treatment.*
Sumatriptan-figure-2 - sumatriptan succinate 25mg 3
The text is describing a figure showing the estimated probability of patients taking a second dose of Sumatriptan Succinate Tablets or other medication to treat migraine within 24 hours after the initial dose. The figure includes data from three controlled trials and shows the probability based on the dosage and time elapsed since the initial dose. No remedication was allowed within 2 hours postdose.*
33261-0662_SUMATRIPTAN-SUCC_25MG - sumatriptan succinate 25mg 4
* The product label images have been analyzed using a combination of traditional computing and machine learning techniques. It should be noted that the descriptions provided may not be entirely accurate as they are experimental in nature. Use the information in this page at your own discretion and risk.